US8831719B2 - External defibrillator with charge advisory algorithm - Google Patents

External defibrillator with charge advisory algorithm Download PDF

Info

Publication number
US8831719B2
US8831719B2 US13/032,400 US201113032400A US8831719B2 US 8831719 B2 US8831719 B2 US 8831719B2 US 201113032400 A US201113032400 A US 201113032400A US 8831719 B2 US8831719 B2 US 8831719B2
Authority
US
United States
Prior art keywords
charge
patient
external defibrillator
analysis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US13/032,400
Other versions
US20110144707A1 (en
Inventor
Joseph L. Sullivan
Patrick F. Kelly
Richard C. Nova
James W. Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Physio-Control Inc
Original Assignee
Physio-Control Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/008,876 priority Critical patent/US7904152B2/en
Application filed by Physio-Control Inc filed Critical Physio-Control Inc
Priority to US13/032,400 priority patent/US8831719B2/en
Publication of US20110144707A1 publication Critical patent/US20110144707A1/en
Assigned to PHYSIO-CONTROL, INC. reassignment PHYSIO-CONTROL, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC.
Assigned to BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS *COLLATERAL TRUSTEE, THE reassignment BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS *COLLATERAL TRUSTEE, THE SECURITY AGREEMENT Assignors: PHYSIO-CONTROL, INC.
Assigned to CITIBANK, N.A., AS COLLATERAL AGENT reassignment CITIBANK, N.A., AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: PHYSIO-CONTROL, INC.
Assigned to MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC. reassignment MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KELLY, PATRICK F., TAYLOR, JAMES W., SULLIVAN, JOSEPH L.
Assigned to MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC. reassignment MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOVA, RICHARD C.
Publication of US8831719B2 publication Critical patent/US8831719B2/en
Application granted granted Critical
Assigned to MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC. reassignment MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC. CORRECTIVE ASSIGNMENT TO CORRECT THE 12/9/2011 ASSIGNMENT FROM R. NOVA AND REPLACE IT WITH THE ORIGINAL 7/21/2005 ASSIGNMENT EXECUTED BY HIM. THE 2011 ASSIGNMENT WAS PREVIOUSLY RECORDED ON REEL 027982 FRAME 0310. ASSIGNOR(S) HEREBY CONFIRMS THE ORIGINAL 7/21/2005 ASSIGNMENT. THE 2011 ASSIGNMENT WAS EXECUTED IN ERROR. Assignors: NOVA, RICHARD C.
Assigned to PHYSIO-CONTROL, INC. reassignment PHYSIO-CONTROL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
Assigned to CITIBANK, N.A., AS COLLATERAL AGENT reassignment CITIBANK, N.A., AS COLLATERAL AGENT FIRST LIEN SECURITY AGREEMENT Assignors: PHYSIO-CONTROL INTERNATIONAL, INC., PHYSIO-CONTROL, INC.
Assigned to CITIBANK, N.A., AS COLLATERAL AGENT reassignment CITIBANK, N.A., AS COLLATERAL AGENT SECOND LIEN SECURITY AGREEMENT Assignors: PHYSIO-CONTROL INTERNATIONAL, INC., PHYSIO-CONTROL, INC.
Assigned to PHYSIO-CONTROL, INC., PHYSIO-CONTROL INTERNATIONAL, INC. reassignment PHYSIO-CONTROL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITIBANK, N.A.
Assigned to PHYSIO-CONTROL, INC., PHYSIO-CONTROL INTERNATIONAL, INC. reassignment PHYSIO-CONTROL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITIBANK, N.A.
Assigned to PHYSIO-CONTROL, INC. reassignment PHYSIO-CONTROL, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CITIBANK, N.A.
Application status is Active legal-status Critical
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3925Monitoring; Protecting
    • A61N1/3931Protecting, e.g. back-up systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3987Heart defibrillators characterised by the timing or triggering of the shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3993User interfaces for automatic external defibrillators

Abstract

An external defibrillator includes a therapy delivery circuit, a sensor, and a processor. The therapy delivery circuit is configured to be electrically charged and to deliver electrical therapy to a patient. The sensor is configured to sense a physiological condition of the patient and generate data indicative of a probability that therapy will be delivered to the patient. The processor is configured to analyze data generated by the sensor to determine whether there is a threshold level of the probability that the therapy delivery will be delivered to the patient, if the probability is at least at the threshold level, charge the therapy delivery circuit, and determine whether therapy delivery is advisable based on the physiological condition of the patient after determining whether the probability is at least at the threshold level.

Description

This application is a divisional of application Ser. No. 11/008,876, filed Dec. 9, 2004, which will issue as U.S. Pat. No. 7,904,152 on Mar. 8, 2011, the entire content of which is hereby incorporated by reference in its entirety.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates generally to external defibrillators, and particularly to charging systems and algorithms for external defibrillators.

2. Technical Background

Sudden Cardiac Arrest (SCA) is a condition in which the heart exhibits a life-threatening abnormal rhythm, or arrhythmia. The most common arrhythmia is Ventricular Fibrillation (VF). When in VF, the heart's rhythm is so chaotic that the heart merely quivers, and is unable to pump blood to the body and brain. This chaotic rhythm is generally referred to as fibrillation. A victim in SCA first loses his or her pulse, then consciousness, and finally the ability to breath. These events happen in a matter of seconds.

An effective treatment for SCA is to deliver an electrical shock using a device called an external defibrillator to defibrillate the heart. Voltage stored by the external defibrillator is applied across the patient's heart by means of electrodes or paddles place on the victim's body, such as the victim's chest, resulting in an electrical current flow through the heart. The brief pulse of electrical current is provided to halt the fibrillation, giving the heart a chance to start beating with a normal rhythm. This delivering of the electrical shock, which is intended to return the heart to normal rhythm, is called defibrillation.

Survival rates for SCA are the highest when defibrillation is conducted within the first few minutes after onset of an arrhythmia, and the person has the best chance of survival if the defibrillation shock is given within the first three minutes of the person's collapse. One study has shown that the chances of resuscitating an individual suffering SCA are reduced by about 7% to about 10% with each minute that lapses between onset of SCA and application of the defibrillation shock. Therefore, rate of survival for SCA victims average less than 2% when defibrillation is delayed ten minutes or more.

There are several types of external defibrillators, including manual defibrillators, which are generally used by medical personnel, and automated external defibrillators, commonly known by the acronym AED, which are designed for use by laypersons. Typically an AED is a small, portable device that analyzes the heart's rhythm and if the analysis determines that a defibrillating shock is advisable, either prompts the user to deliver a defibrillation shock or delivers a defibrillation shock without user interaction. Once a typical AED is activated, it can guide the user through each step of the defibrillation process by providing instructions in the form of aural or visual prompts.

Commercially available AED's analyze the patient's heart rhythm and charge the energy storage capacitor before a defibrillating shock can be delivered to the patient. This is done using a decision-making algorithm commonly referred to as a shock advisory algorithm. Current commercially available defibrillators analyze the ECG first to determine if the patient's heart is in a condition where delivery of a defibrillating shock is advisable, and after this analysis is done, charge if a shock is recommended. Typically, a shock advisory algorithm may take from about five to about 8 or more seconds to analyze, and the capacitor in a typical AED typically takes about 8 to about 10 or more seconds to charge up in preparation for delivery of a defibrillating shock. Time delays such as this have a negative impact on patient survival and should be minimized; the amount of time required for a defibrillator to get ready to deliver should be kept as short as possible.

Several approaches to reducing the time to shock have been proposed. One approach is to design device hardware so as to minimize the charging time. Unfortunately, this can raise manufacturing costs. Another approach is to commence charge of the defibrillator upon turning the device on. If the shock advisory analysis indicates that the patient requires a shock, then the device is ready to deliver the energy. But, if the analysis indicates that no shock is required, then the device will internally dump the stored charge. This results in a waste of energy that can result in increase cost of operation due to increased need for battery replacement. There also is concern about the potential for accidental delivery of energy since the charge will become available whenever the device is activated, whether needed for therapy or not.

SUMMARY OF THE INVENTION

This disclosure is directed to techniques for charging a therapy delivery circuit of an external defibrillator. In one example, an external defibrillator includes a therapy delivery circuit, a sensor, and a processor. The therapy delivery circuit is configured to be electrically charged and to deliver electrical therapy to a patient. The sensor is configured to sense a physiological condition of the patient and generate data indicative of a probability that therapy will be delivered to the patient. The processor is configured to analyze data generated by the sensor to determine whether there is a threshold level of the probability that the therapy delivery will be delivered to the patient, if the probability is at least at the threshold level, charge the therapy delivery circuit, and determine whether therapy delivery is advisable based on the physiological condition of the patient after determining whether the probability is at least at the threshold level.

Additional features and advantages of the invention will be set forth in the detailed description which follows, and in part will be readily apparent to those skilled in the art from that description or recognized by practicing the invention as described herein, including the detailed description which follows, the claims, as well as the appended drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a schematic representation of an external defibrillator according to an embodiment of the invention.

FIG. 2 is a flow chart of a charge advisory analysis process of an embodiment of the invention.

FIG. 3 is a timing diagram for a first scenario of use of the embodiment of FIG. 2.

FIG. 4 is a timing diagram for a second scenario of use of the embodiment of FIG. 2.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Reference will now be made in detail to the present preferred embodiments of the invention, an example of which is illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts. An exemplary embodiment of the medical device of the present invention is shown in FIG. 1, and is designated generally by reference numeral 18.

In FIG. 1, defibrillator 12 is shown coupled to a patient 16 by electrodes 18A and 18B (collectively “electrodes 18”). Electrodes 18 may include hand-held electrode paddles or adhesive electrode pads placed on the skin of patient 16. Electrodes 18 are coupled to defibrillator 12 via respective conductors 20A and 20B (collectively “conductors 20”) and an interface 22. In a typical application, interface 22 includes a receptacle, and conductors 20 plug into the receptacle.

Interface 22 includes a switch (not shown in FIG. 1) that, when activated, couples therapy delivery circuitry 24 to electrodes 18 for delivery of energy to patient 16 via electrodes 18 in the form of a defibrillation shock. The switch may be of conventional design and may be formed, for example, of electrically operated relays. Alternatively, the switch may comprise an arrangement of solid-state devices such as silicon-controlled rectifiers or insulated gate bipolar transistors.

Therapy delivery circuitry 24 includes components, such as one or more capacitors, that store the energy to be delivered to patient 16 as a defibrillation shock. Before a defibrillation shock may be delivered to patient 16, these energy storage components are charged by charging circuitry, such as a flyback charger, that transfers energy from energy storage device 14 such as a battery to the components. A processor 26 directs the charging circuitry to charge the energy storage components to a selected voltage level that is determined based on a selected energy level for the defibrillation shock to be delivered to patient 16.

Defibrillator 12 may be a manual defibrillator or an AED. Where defibrillator 12 is a manual defibrillator, a caregiver using defibrillator 12 may select an energy level for each defibrillation shock delivered to patient 12. Processor 26 may receive the selection made by the caregiver via a user interface 28, which may include input devices, such as a keypad and various buttons or dials, and output devices, such as various indicator lights, a cathode ray tube (CRT), light emitting diode (LED), or liquid crystal display (LCD) screen, and a speaker. Where defibrillator 12 is an AED, processor 26 may select an energy level based on protocol stored in a memory 30 and the number of defibrillation shocks already delivered to patient 16. The protocol may define a preprogrammed progression of energy levels and numbers of shocks to be delivered at each energy level.

When the energy stored by therapy delivery circuitry 24 reaches the desired energy level, processor 26 controls user interface 28 to provide an indication to the caregiver that defibrillator 12 is ready to deliver a defibrillation shock to patient 16, such as an indicator light or a voice prompt. The defibrillation shock may be delivered manually or automatically. In a manual defibrillator and some AEDs, the user may direct processor 26 to deliver the defibrillation shock via user interface 28 by, for example pressing a button. In some other AEDs, the processor 26 will automatically cause delivery of the defibrillating shock without further user interaction. In either case, processor 26 activates the switches of interface 22 to electrically connect therapy delivery circuit 24 to electrodes 18, and thereby deliver the defibrillation shock to patient 16.

Processor 26 may perform other functions as well, such as monitoring electrical activity of the heart of patient 16 sensed via electrodes 18. Processor 26 may determine whether the heart of patient 16 is fibrillating based upon the sensed electrical activity in order to determine whether a defibrillation shock should be delivered to patient 16. Where a defibrillation shock has already been delivered, processor 26 may evaluate the efficacy of the delivered defibrillation shock by determining if the heart is still fibrillating in order to determine whether an additional defibrillation shock is warranted. Processor 26 may automatically deliver defibrillation shocks based on these determinations, or may advise the caregiver of these determinations via user interface 28.

Processor 26 may display an electrocardiogram (ECG) that reflects the sensed electrical activity via user interface 28. Further, processor 26 may control delivery of other types of therapy to patient 16 via electrodes 18, such as cardioversion or pacing therapy. Where defibrillator 12 is more fully featured, e.g., a manual paramedic or hospital defibrillator, defibrillator 12 may also include additional sensors (not shown) coupled to processor 26, such as sensors to measure blood oxygen saturation, temperature, blood pressure, and the amount of carbon dioxide in the air inhaled or exhaled by patient 16.

Processor 26 may, for example, include one or more of a microprocessor, digital signal processor (DSP), application specific integrated circuit (ASIC), field programmable gate array (FPGA), or other logic circuitry. In addition to various values, look-up tables, or equations described above, memory 30 may include program instructions that cause processor 26 to perform the functions attributed to processor 26 herein. Memory 30 may include any of a variety of solid state, magnetic or optical media, such as random access memory (RAM), read-only memory (ROM), CD-ROM, magnetic disk, electrically erasable programmable ROM (EEPROM), or flash memory.

In an embodiment of the invention, processor 26 will perform a charge advisory analysis that will determine whether to commence charging the one or more capacitors in the therapy delivery circuitry prior to the determination by the shock advisory algorithm of whether delivery of a shock is advised. In some embodiments, this charge advisory analysis may also determine the rate at which the charging is performed. A process for the charge advisory analysis is illustrated in the flowchart of FIG. 2. In the illustrated embodiment, after the defibrillator is turned on in a first step 32, the defibrillator provides data on sensed parameters to processor 26 in a second step 34. These parameters may include the patient's physiological parameters such as ECG, or device parameters indicative of some condition of the defibrillator 12 such as electrode impedance or user interaction with the defibrillator 12, or a combination of patient parameters and device parameters. If the sensed parameters meet criteria that would indicate some probability that a charge will be needed, then the processor would, in step 38, direct the energy storage device 14 to commence charging the therapy delivery circuitry 24. If the sensed parameters do not meet the charging criteria, then charging would not commence at that point in time. If, however, in step 40, the clinical analysis results in shock being advised, then charging would be commenced at completion of the clinical determination that shock is advised.

The charge advisory analysis may use relatively simple criteria for the charge decision. In one embodiment, the processor 26 will analyze a short segment of ECG and begin charging if all of the following criteria are met: 1) no QRS complexes are detected, 2) a flat line is not detected, and 3) the electrodes are attached to a patient. This analysis can be done in a small fraction of the time needed for the clinical analysis to be completed. Other criteria that would indicate a desired probability that a charge will be needed may, of course, be used in alternative embodiments of the invention. The desired degree of probability may be low. In determining the desired degree of probability level for a particular application, one may wish to weigh the desirability of commencing charging prior to a Shock Advised determination against that of avoiding charging where no shock will be advised, so as to preserve battery power and avoid any other deleterious effects of having charged up a defibrillator where no shock is called for.

In some applications, it may be desirable to commence charging if there is simply a non-zero probability that a shock will be advised. In an embodiment suitable for such an application, the parameter detected in step 34 would be electrode impedance, and the criteria for charging in step 36 would be whether the electrode impendence is within a range that would indicated the electrodes are attached to the patient 16. In this embodiment, after the defibrillator is turned on, it measures the electrode impedance to see if the electrodes are attached to a patient. Electrode impedance within a specified range, typically between 10 to 300 ohms, would be generally reliable indication that the electrodes 18 have been applied to the patient 16. Impedance outside this range would indicate that the electrodes 18 are not connected to a patient. Connection of electrodes to a patient would indicate a non-zero probability that a shock will be needed.

If the charge analysis indicates electrodes are not attached to a patient, then the defibrillator would not begin charging. The charge advisory analysis could be repeated until either the electrodes are attached to a patient or the defibrillator is turned off.

FIGS. 3 and 4 schematically illustrate the timing involved in two different scenarios in which embodiments of the invention are used. In both of these figures, the horizontal arrow represents progression in time. In FIG. 3, the defibrillator is activated at T0. The charge advisory analysis is performed from T0 to T1. In the scenario shown in FIG. 3, the charge advisory analysis results in a determination that charging should be commenced, and charging is commenced approximately at time T1. The clinical shock advisory analysis is performed from T0 to T2. At T2, the shock advisory analysis determines a shock is advised, and so charging is continued until it is completed at T3.

In the scenario shown in FIG. 4, the defibrillator is activated at T0′. The charge advisory analysis is performed from T0′ to T1′. In the scenario shown in FIG. 4, a charge advisory analysis does not result in a determination that charging should be commenced, and charging is not commenced at time T1′. This would be the case the case where the sensed parameters input into the charging decision do not meet the chosen criteria. The clinical shock advisory analysis is performed from T0′ to T2′. At T2′, the shock advisory analysis determines a shock is advised, and so charging commences at approximately T2′ and continues until it is completed at T3′. The time it takes to charge the defibrillator for both scenarios would be substantially equal, i.e., (T3−T1)=(T3′−T2′). It will be noted, however, that the time from activation to the point where the defibrillator is fully charged and ready for delivery of shock in the scenario of FIG. 3, (T3−T0) is substantially less than the corresponding time period in the scenario of FIG. 4, (T3′−T0′). Timing from activation of a defibrillator until readiness for shock delivery for a defibrillator that does not employ a charge advisory analysis according to an embodiment of the invention would be substantially the same as in the FIG. 4 scenario. If, for a defibrillator 12 employing a shock advisory analysis according to the invention, charging criteria are chosen so that, in most cases a determination to commence charging will be made prior to the shock advisory algorithm's determination that shock is advisable, then there will be a significant time saving in preparation for shock delivery in most cases where shock is advised.

In another alternative embodiment, a charge advisory analysis process is capable of providing a determination of whether charging should be commenced based on sensed parameters indicative of the probability of whether a shock will be advised, with an increasing confidence level over time. In an illustrative embodiment, this could be done by analyzing a first segment of a patient ECG and rendering a preliminary decision based on that analysis. A second segment of the ECG subsequent to the first segment could then be analyzed. If the two analyses agree, then one would have an increased confidence that the initial determination was correct. Similarly, additional segments could be analyzed on a continuous basis, providing increased confidence over time.

The progressive output of the charge advisory analysis in this embodiment could be used to provide intelligent control of the defibrillator capacitor charger. For example, the capacitor charger could be turned on at a first charge rate when the first Charge Advised determination is made. If a second Charge Advised determination agrees, then the charge rate could be increased. Finally, if the Shock Advisory Algorithm provides a shock advised decision before the capacitor is fully charged, then the charge rate would be increased to its maximum level. Another example of how charging could be controlled would be to charge the capacitor to a first charge level if an initial Charge Advised determination is made, and then charge to a second level if a second Charge Advised determination is made. This process of making progressive charge advisability determinations and charging to progressively higher levels may be repeated. If the Shock Advisory Algorithm advises that shock delivery is advised, charge would be completed, if it had not already been completed.

This progressive control of the capacitor charger provides a couple of benefits. One benefit is a reduced risk of capacitor charger noise artifact appearing on the ECG signal, which is one of the possible drawbacks of charging while an ECG analysis is performed. The other benefit is the reduced likelihood that the energy will be wasted.

This invention proposes a method of reducing the shock time delay while at the same time reducing the risk of wasted energy through unnecessary charging, reducing the hazard of having energy available when it is not required and minimizing the effect of charging artifact on the signal analysis. This invention proposes a method and device in which clinical analysis algorithms may operate, providing timely assessment of the patient status, and correctly preparing the device to support a patient in the most rapid fashion possible.

In the embodiments described above, the charging criterion is chosen to result in a Charging Advised determination in cases where a desired likelihood or probability that a shock will be advised is met. The parameters upon which this determination is made may include any of a signal such as ECG, or any of subset of similar signals giving a measure of cardiac activity, including, for example, ECG from multiple sites, transthoracic impedance, electric field plethysmography, photoplethysmography, cardiokymographic, ballistocardiographic, or acoustic plethysmography.

Data on the state of the defibrillator or how a user is interacting with a defibrillator may be used to make a determination of whether the desired level of probability has been met. These may include, for example, whether the user has applied the electrodes to the patient, or other operator actions such as connecting the electrodes to the defibrillator, opening the electrode pouch, removing the electrodes from the pouch, removing the backing material from the electrodes, or performing CPR on the patient

It will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the spirit and scope of the invention. Thus, it is intended that the present invention covers the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.

It is to be understood that both the foregoing general description and the following detailed description are merely exemplary of the invention, and are intended to provide an overview or framework for understanding the nature and character of the invention as it is claimed. The accompanying drawings are included to provide a further understanding of the invention, and are incorporated in and constitute a part of this specification. The drawings illustrate various embodiments of the invention and together with the description serve to explain the principles and operation of the invention.

Claims (25)

What is claimed is:
1. An external defibrillator comprising:
a therapy delivery circuit configured to be electrically charged and to deliver electrical therapy to a patient;
a sensor configured to sense a physiological condition of the patient and generate data indicative of a probability that therapy will be delivered to the patient; and
a processor configured to:
perform a charge advisory analysis using the data generated by the sensor and a first set of criteria and initiate charging the therapy delivery circuit based on the outcome of the charge advisory analysis; and
perform a shock advisory analysis that is a different analysis than the charge advisory analysis and uses a second set of criteria that is different than the charge advisory analysis criteria, and initiate charging the therapy delivery circuit based on the outcome of the shock advisory analysis when charging has not been initiated based on the outcome of the charge advisory analysis,
wherein the charge advisory analysis is performed during a first time period and the shock advisory analysis is performed during a second time period that overlaps the first time period.
2. The external defibrillator of claim 1, wherein the data indicative of the probability that therapy will be delivered to the patient generated by the sensor comprises data indicative of cardiac activity of the patient.
3. The external defibrillator of claim 1, wherein the data indicative of the probability that therapy will be delivered to the patient generated by the sensor comprises electrocardiogram (ECG) signals.
4. The external defibrillator of claim 3, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis at least based on the ECG signals from the sensor does not comprise a flat line signal.
5. The external defibrillator of claim 3, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis at least based on the ECG signals from the sensor does not comprise any QRS complexes.
6. The external defibrillator of claim 1, wherein the data indicative of the probability that therapy will be delivered to the patient generated by the sensor comprises data indicating that at least one electrode connected to the external defibrillator has been applied to the patient.
7. The external defibrillator of claim 3, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis at least based on the ECG signals from the sensor does not comprise a flat line signal and any QRS complexes, and an indication that at least one electrode connected to the external defibrillator has been applied to the patient.
8. The external defibrillator of claim 1, in which the processor is further configured to control the therapy delivery circuit to deliver electrical therapy to the patient.
9. The external defibrillator of claim 8, wherein the processor is further configured to control the therapy delivery circuit to deliver electrical therapy to the patient based at least on a user input to the external defibrillator.
10. The external defibrillator of claim 1 in which charging the therapy delivery circuit based on the outcome of the charge advisory analysis comprises charging the therapy delivery circuit to a first charge level; and in which
the therapy delivery circuit charges from the first charge level up to a charge level at which the device is capable of delivering therapy based on the outcome of the shock advisory analysis.
11. An external defibrillator comprising:
a therapy delivery circuit configured to be electrically charged and to deliver electrical therapy to a patient;
a sensor configured to sense a physiological condition of the patient and generate data indicative of a probability that therapy will be delivered to the patient; and
a processor configured to:
perform a charge advisory analysis using the data generated by the sensor and initiate charging the therapy delivery circuit based on the outcome of the charge advisory analysis, in which performing a charge advisory analysis comprises comparing the data indicative of the probability that therapy will be delivered to the patient to a first threshold level and to a second threshold level, and in which:
if the probability is at least at the first threshold level, the processor is configured to charge the therapy delivery circuit at a first charge rate; and
if the probability is at least at the second threshold level, the processor is configured to charge the therapy delivery circuit at a second charge rate that is faster than the first charge rate; and
perform a shock advisory analysis that is different than the charge advisory analysis, and initiate charging the therapy delivery circuit based on the outcome of the shock advisory analysis when charging has not been initiated based on the outcome of the charge advisory analysis.
12. An external defibrillator comprising:
a therapy delivery circuit configured to be electrically charged and to deliver electrical therapy to a patient;
a sensor configured to generate data derived from a physiological condition of a patient, the data including sensed parameter data used in determining whether therapy will be delivered to the patient; and
a processor configured to:
perform a charge advisory analysis using the sensed parameter data generated by the sensor and a first set of criteria and initiate charging the therapy delivery circuit based on the outcome of the charge advisory analysis; and
perform a shock advisory analysis that is a different analysis than the charge advisory analysis and uses a second set of criteria that is different than the charge advisory analysis criteria, and initiate charging the therapy delivery circuit based on the outcome of the shock advisory analysis when charging has not been initiated based on the outcome of the charge advisory analysis,
wherein the charge advisory analysis is performed during a first time period and the shock advisory analysis is performed during a second time period that overlaps the first time period.
13. The external defibrillator of claim 12, wherein the data generated by the sensor comprises data indicative of cardiac activity of the patient.
14. The external defibrillator of claim 12, wherein the data generated by the sensor comprises electrocardiogram (ECG) signals.
15. The external defibrillator of claim 14, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis based on the ECG signals from the sensor does not comprise a flat line signal.
16. The external defibrillator of claim 14, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis based on the ECG signals from the sensor does not comprise any QRS complexes.
17. The external defibrillator of claim 12, wherein the data generated by the sensor comprises data indicating that at least one electrode connected to the external defibrillator has been applied to the patient.
18. The external defibrillator of claim 14, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis at least based on the ECG signals from the sensor does not comprise a flat line signal and any QRS complexes, and an indication that at least one electrode connected to the external defibrillator has been applied to the patient.
19. The external defibrillator of claim 12, wherein the processor is further configured to initiate charging if the outcome of the charge advisory analysis indicates a non-zero probability that a shock will be advised.
20. The external defibrillator of claim 12, in which the processor is further configured to control the therapy delivery circuit to deliver electrical therapy to the patient.
21. The external defibrillator of claim 20, wherein the processor is further configured to control the therapy delivery circuit to deliver electrical therapy to the patient based at least on a user input to the external defibrillator.
22. The external defibrillator of claim 12 in which charging the therapy delivery circuit based on the outcome of the charge advisory analysis comprises charging the therapy delivery circuit to a first charge level; and in which
the therapy delivery circuit charges from the first charge level up to a charge level at which the device is capable of delivering therapy based on the outcome of the shock advisory analysis.
23. The external defibrillator of claim 12, wherein the shock advisory analysis is performed using data generated by the sensor.
24. The external defibrillator of claim 1, wherein the shock advisory analysis is performed using data generated by the sensor.
25. The external defibrillator of claim 11, wherein the charge advisory analysis is performed using a first set of criteria and the shock advisory analysis is performed using a second set of criteria that is different than the first set of criteria.
US13/032,400 2004-12-09 2011-02-22 External defibrillator with charge advisory algorithm Active 2025-03-18 US8831719B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/008,876 US7904152B2 (en) 2004-12-09 2004-12-09 External defibrillator with charge advisory algorithm
US13/032,400 US8831719B2 (en) 2004-12-09 2011-02-22 External defibrillator with charge advisory algorithm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/032,400 US8831719B2 (en) 2004-12-09 2011-02-22 External defibrillator with charge advisory algorithm

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/008,876 Division US7904152B2 (en) 2004-12-09 2004-12-09 External defibrillator with charge advisory algorithm

Publications (2)

Publication Number Publication Date
US20110144707A1 US20110144707A1 (en) 2011-06-16
US8831719B2 true US8831719B2 (en) 2014-09-09

Family

ID=36585060

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/008,876 Active 2027-12-21 US7904152B2 (en) 2004-12-09 2004-12-09 External defibrillator with charge advisory algorithm
US13/032,400 Active 2025-03-18 US8831719B2 (en) 2004-12-09 2011-02-22 External defibrillator with charge advisory algorithm

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/008,876 Active 2027-12-21 US7904152B2 (en) 2004-12-09 2004-12-09 External defibrillator with charge advisory algorithm

Country Status (1)

Country Link
US (2) US7904152B2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056652A1 (en) * 2000-02-04 2001-08-09 Zmd Corporation Integrated resuscitation
US7920917B2 (en) * 2003-07-17 2011-04-05 Physio-Control, Inc. External defibrillator and methods for operating the external defibrillator
US6961612B2 (en) * 2003-02-19 2005-11-01 Zoll Medical Corporation CPR sensitive ECG analysis in an automatic external defibrillator
US20050101889A1 (en) 2003-11-06 2005-05-12 Freeman Gary A. Using chest velocity to process physiological signals to remove chest compression artifacts
US7565194B2 (en) * 2004-05-12 2009-07-21 Zoll Medical Corporation ECG rhythm advisory method
WO2005112749A1 (en) 2004-05-12 2005-12-01 Zoll Medical Corporation Ecg rhythm advisory method
US7904152B2 (en) * 2004-12-09 2011-03-08 Physio-Control, Inc. External defibrillator with charge advisory algorithm
EP2172245B1 (en) 2008-10-03 2017-04-12 Schiller Medical S.A.S. Apparatus for defibrillation delivery decision
US9168386B2 (en) * 2009-02-20 2015-10-27 Comptolife, Llc Adaptation of the common notebook, laptop computer, netbook and tablet PC computer to enable each to be used as an automated external defibrillator (AED) to treat victims of sudden cardiac arrest
US8594784B2 (en) 2009-02-20 2013-11-26 Babric Life Science Innovations, Llc. Kits and methods for retrofitting and adapting common notebooks, laptop computers, and tablets, to enable each to be used as an automated external defibrillator (AED), and as a manual defibrillator
US8265737B2 (en) * 2009-10-27 2012-09-11 Cameron Health, Inc. Methods and devices for identifying overdetection of cardiac signals
US9126055B2 (en) 2012-04-20 2015-09-08 Cardiac Science Corporation AED faster time to shock method and device
EP3027274A4 (en) 2013-08-01 2017-04-26 Zoll Medical Corporation Systems and methods for utilizing identification devices in a wearable medical therapy device
US10118047B2 (en) * 2016-01-03 2018-11-06 Igor Abramov Automatic defibrillation system
WO2018111688A1 (en) 2016-12-12 2018-06-21 Revive Solutions, Inc. Defibrillator

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179945A (en) 1978-09-05 1979-12-25 The Singer Company Variable step size impulse drive
US5097830A (en) 1990-03-30 1992-03-24 Laerdal Manufacturing Corporation Defibrillator with reliability verification
US5111813A (en) 1990-05-18 1992-05-12 Hewlett-Packard Company Defibrillation employing an impedance-corrected delivered energy
US5191884A (en) 1987-09-02 1993-03-09 Telectronics N.V. Reconfirmation prior to shock for implantable defibrillation
US5391187A (en) 1994-02-22 1995-02-21 Zmd Corporation Semiautomatic defibrillator with heart rate alarm driven by shock advisory algorithm
US5423863A (en) 1990-12-13 1995-06-13 Odam, S.A. Method of recognizing a ventricular cardiac pathological condition for automatic defibrillation purposes, and monitor-defibrillator for implementing said method
US5496349A (en) 1994-03-11 1996-03-05 Physio-Control Corporation Method and system for automatic or semi-automatic defilbrillation using redundant processing
US5607454A (en) 1993-08-06 1997-03-04 Heartstream, Inc. Electrotherapy method and apparatus
US5700281A (en) 1996-06-04 1997-12-23 Survivalink Corporation Stage and state monitoring automated external defibrillator
US5797969A (en) 1995-08-01 1998-08-25 Survivalink Corporation One button lid activated automatic external defibrillator
US6005370A (en) 1998-01-26 1999-12-21 Physio-Control Manufacturing Corporation Automatic rate control for defibrillator capacitor charging
US6029085A (en) 1997-04-09 2000-02-22 Survivalink Corporation Charging and safety control for automated external defibrillator and method
US6029084A (en) 1995-04-13 2000-02-22 Alistair Ross MacNicol Therapeutic field generator
US6241751B1 (en) 1999-04-22 2001-06-05 Agilent Technologies, Inc. Defibrillator with impedance-compensated energy delivery
US6289243B1 (en) 1999-12-01 2001-09-11 Cardiac Science, Inc. Automatic external cardioverter/defibrillator with tachyarrhythmia detector using a modulation (amplitude and frequency) domain function
US6304773B1 (en) 1998-05-21 2001-10-16 Medtronic Physio-Control Manufacturing Corp. Automatic detection and reporting of cardiac asystole
US6553257B2 (en) 2001-03-13 2003-04-22 Koninklijke Philips Electronics N.V. Interactive method of performing cardipulmonary resuscitation with minimal delay to defibrillation shocks
US6553251B1 (en) 1999-11-05 2003-04-22 Polar Electro Oy Method and arrangement for heartbeat detection
US6658290B1 (en) * 2000-06-12 2003-12-02 Cardiac Science, Inc. Public access defibrillator
US20040064157A1 (en) * 2002-09-30 2004-04-01 Norton John D. Method and apparatus for maintaining energy storage in an electrical storage device
US20040172068A1 (en) * 2003-01-31 2004-09-02 Sullivan Joseph L. Apparatus and methods for fibrillation and defibrillation
US20040249418A1 (en) * 2001-09-21 2004-12-09 Mills Desmond Bryan Defibrillator
US7027863B1 (en) * 1999-10-25 2006-04-11 Impulse Dynamics N.V. Device for cardiac therapy
US20060129190A1 (en) 2004-12-09 2006-06-15 Sullivan Joseph L External defibrillator with charge advisory algorithm
US7242979B1 (en) 2002-09-20 2007-07-10 Medtronic Physio-Control Manufacturing Corporation External defibrillator and methods for operating the external defibrillator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179945A (en) * 1991-01-17 1993-01-19 Cardiac Pacemakers, Inc. Defibrillation/cardioversion system with multiple evaluation of heart condition prior to shock delivery
US5817132A (en) * 1997-05-09 1998-10-06 Cedars-Sinai Medical Center Defibrillation apparatus and method
US6754526B2 (en) * 2000-11-13 2004-06-22 Medtronic Physio-Control Corp Defibrillator with a multiple-mode interface

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179945A (en) 1978-09-05 1979-12-25 The Singer Company Variable step size impulse drive
US5191884A (en) 1987-09-02 1993-03-09 Telectronics N.V. Reconfirmation prior to shock for implantable defibrillation
US5097830A (en) 1990-03-30 1992-03-24 Laerdal Manufacturing Corporation Defibrillator with reliability verification
US5111813A (en) 1990-05-18 1992-05-12 Hewlett-Packard Company Defibrillation employing an impedance-corrected delivered energy
US5423863A (en) 1990-12-13 1995-06-13 Odam, S.A. Method of recognizing a ventricular cardiac pathological condition for automatic defibrillation purposes, and monitor-defibrillator for implementing said method
US5607454A (en) 1993-08-06 1997-03-04 Heartstream, Inc. Electrotherapy method and apparatus
US5391187A (en) 1994-02-22 1995-02-21 Zmd Corporation Semiautomatic defibrillator with heart rate alarm driven by shock advisory algorithm
US5496349A (en) 1994-03-11 1996-03-05 Physio-Control Corporation Method and system for automatic or semi-automatic defilbrillation using redundant processing
US6029084A (en) 1995-04-13 2000-02-22 Alistair Ross MacNicol Therapeutic field generator
US5797969A (en) 1995-08-01 1998-08-25 Survivalink Corporation One button lid activated automatic external defibrillator
US5700281A (en) 1996-06-04 1997-12-23 Survivalink Corporation Stage and state monitoring automated external defibrillator
US6029085A (en) 1997-04-09 2000-02-22 Survivalink Corporation Charging and safety control for automated external defibrillator and method
US6005370A (en) 1998-01-26 1999-12-21 Physio-Control Manufacturing Corporation Automatic rate control for defibrillator capacitor charging
US6304773B1 (en) 1998-05-21 2001-10-16 Medtronic Physio-Control Manufacturing Corp. Automatic detection and reporting of cardiac asystole
US6241751B1 (en) 1999-04-22 2001-06-05 Agilent Technologies, Inc. Defibrillator with impedance-compensated energy delivery
US7027863B1 (en) * 1999-10-25 2006-04-11 Impulse Dynamics N.V. Device for cardiac therapy
US6553251B1 (en) 1999-11-05 2003-04-22 Polar Electro Oy Method and arrangement for heartbeat detection
US6289243B1 (en) 1999-12-01 2001-09-11 Cardiac Science, Inc. Automatic external cardioverter/defibrillator with tachyarrhythmia detector using a modulation (amplitude and frequency) domain function
US6658290B1 (en) * 2000-06-12 2003-12-02 Cardiac Science, Inc. Public access defibrillator
US6553257B2 (en) 2001-03-13 2003-04-22 Koninklijke Philips Electronics N.V. Interactive method of performing cardipulmonary resuscitation with minimal delay to defibrillation shocks
US20040249418A1 (en) * 2001-09-21 2004-12-09 Mills Desmond Bryan Defibrillator
US7242979B1 (en) 2002-09-20 2007-07-10 Medtronic Physio-Control Manufacturing Corporation External defibrillator and methods for operating the external defibrillator
US20040064157A1 (en) * 2002-09-30 2004-04-01 Norton John D. Method and apparatus for maintaining energy storage in an electrical storage device
US20040172068A1 (en) * 2003-01-31 2004-09-02 Sullivan Joseph L. Apparatus and methods for fibrillation and defibrillation
US20060129190A1 (en) 2004-12-09 2006-06-15 Sullivan Joseph L External defibrillator with charge advisory algorithm

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Tchoudovski et al., "New Approach in Developing of the Algorithms for Resuscitation Assistance," Proceedings of the 26th Annual International Conference of the IEEE EMBS, San Fransisco, CA, Sep. 1-5, 2004. pp. 956-959.
Yi-Sheng, Zhu et al., "Detection of Ventricular Fibrillation by Sequential Testing," Biomedical Engineering Department, John Hopkins Medical School, Baltimore, MD IEEE 1989 pp. 325-328.

Also Published As

Publication number Publication date
US20060129190A1 (en) 2006-06-15
US20110144707A1 (en) 2011-06-16
US7904152B2 (en) 2011-03-08

Similar Documents

Publication Publication Date Title
US9144683B2 (en) Post-shock treatment in a subcutaneous device
US5607454A (en) Electrotherapy method and apparatus
EP0528751B1 (en) Impedance based automatic pulse duration adjustment for defibrillation shock delivery
US7627375B2 (en) Implantable cardiac stimulus methods
US7502645B2 (en) Current waveforms for anti-bradycardia pacing for a subcutaneous implantable cardioverter-defibrillator
US8331574B2 (en) Automatic external defibrillator with enhanced clarity of audible prompts
US5179946A (en) Apparatus and method for arrhythmia detection by variations in the transcardiac impedance between defibrillation patches
US7076296B2 (en) Method of supplying energy to subcutaneous cardioverter-defibrillator and pacer
US5474574A (en) Automatic external cardioverter/defibrillator
US20020035376A1 (en) Biphasic waveform for anti-tachycardia pacing for a subcutaneous implantable cardioverter-defibrillator
JP4267912B2 (en) Subcutaneous Only Implantable and integrated defibrillator
US20140249604A1 (en) Method for detecting and treating ventricular arrhythmia
US20070239052A1 (en) Method and apparatus for verifying a determined cardiac event in a medical device based on detected variation in hemodynamic status
Deakin et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: automated external defibrillators, defibrillation, cardioversion and pacing
EP1289603B1 (en) A public access defibrillator
US6134468A (en) Method and apparatus for reducing defibrillation energy
US9289134B2 (en) Defibrillator display
JP5184516B2 (en) Simplified biphasic defibrillator circuit has a make-only switching
JP4262596B2 (en) Method and apparatus for controlling the high voltage and delivery of anti-tachycardia pacing therapy in an implantable medical device
US7979122B2 (en) Implantable sudden cardiac death prevention device with reduced programmable feature set
US5269301A (en) Multimode system for monitoring and treating a malfunctioning heart
US6711442B1 (en) Method and apparatus for reduction of pain from electric stimulation therapies
US6134479A (en) Electrode triad for external defibrillation
AU683136B2 (en) An implantable atrial defibrillator having an intermittently activated fibrillation detector
US8036744B2 (en) Cardiac rhythm management system with defibrillation threshold prediction

Legal Events

Date Code Title Description
AS Assignment

Owner name: PHYSIO-CONTROL, INC., WASHINGTON

Free format text: CHANGE OF NAME;ASSIGNOR:MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC.;REEL/FRAME:027008/0918

Effective date: 20061201

AS Assignment

Owner name: BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS *C

Free format text: SECURITY AGREEMENT;ASSIGNOR:PHYSIO-CONTROL, INC.;REEL/FRAME:027765/0861

Effective date: 20120130

AS Assignment

Owner name: CITIBANK, N.A., AS COLLATERAL AGENT, NEW YORK

Free format text: SECURITY AGREEMENT;ASSIGNOR:PHYSIO-CONTROL, INC.;REEL/FRAME:027763/0881

Effective date: 20120130

AS Assignment

Owner name: MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC., WASHIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NOVA, RICHARD C.;REEL/FRAME:027982/0310

Effective date: 20111209

Owner name: MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC., WASHIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SULLIVAN, JOSEPH L.;KELLY, PATRICK F.;TAYLOR, JAMES W.;SIGNING DATES FROM 20050318 TO 20050721;REEL/FRAME:027982/0276

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: MEDTRONIC EMERGENCY RESPONSE SYSTEMS, INC., WASHIN

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE 12/9/2011 ASSIGNMENT FROM R. NOVA AND REPLACE IT WITH THE ORIGINAL 7/21/2005 ASSIGNMENT EXECUTED BY HIM. THE 2011 ASSIGNMENT WAS PREVIOUSLY RECORDED ON REEL 027982 FRAME 0310. ASSIGNOR(S) HEREBY CONFIRMS THE ORIGINAL 7/21/2005 ASSIGNMENT. THE 2011 ASSIGNMENT WAS EXECUTED IN ERROR;ASSIGNOR:NOVA, RICHARD C.;REEL/FRAME:036214/0693

Effective date: 20050721

AS Assignment

Owner name: PHYSIO-CONTROL, INC., WASHINGTON

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.;REEL/FRAME:037519/0240

Effective date: 20150605

AS Assignment

Owner name: CITIBANK, N.A., AS COLLATERAL AGENT, NEW YORK

Free format text: FIRST LIEN SECURITY AGREEMENT;ASSIGNORS:PHYSIO-CONTROL, INC.;PHYSIO-CONTROL INTERNATIONAL, INC.;REEL/FRAME:037532/0828

Effective date: 20150605

AS Assignment

Owner name: CITIBANK, N.A., AS COLLATERAL AGENT, NEW YORK

Free format text: SECOND LIEN SECURITY AGREEMENT;ASSIGNORS:PHYSIO-CONTROL, INC.;PHYSIO-CONTROL INTERNATIONAL, INC.;REEL/FRAME:037559/0601

Effective date: 20150605

AS Assignment

Owner name: PHYSIO-CONTROL, INC., WASHINGTON

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:038376/0806

Effective date: 20160405

Owner name: PHYSIO-CONTROL INTERNATIONAL, INC., WASHINGTON

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:038379/0001

Effective date: 20160405

Owner name: PHYSIO-CONTROL INTERNATIONAL, INC., WASHINGTON

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:038378/0028

Effective date: 20160405

Owner name: PHYSIO-CONTROL, INC., WASHINGTON

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:038379/0001

Effective date: 20160405

Owner name: PHYSIO-CONTROL, INC., WASHINGTON

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CITIBANK, N.A.;REEL/FRAME:038378/0028

Effective date: 20160405

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551)

Year of fee payment: 4